Frequency of von Willebrand Disease Among Children With Bleeding Disorders at a Tertiary Care Hospital

Muhammad Anees Farooqi1, Afsheen Batool Raza1, Ahmad Yar1, Safwan Ahmad2, Muhammad Usman Javed3
1Department of Paediatric Medicine, The Children’s Hospital and University of Child Health Sciences, Lahore, Pakistan
2Department of Paediatric Haematology and Oncology, The Children’s Hospital and Institute of Child Health, Multan, Pakistan
3Department of Pathology, Sahara Medical College, Narowal, Pakistan
DOI: https://doi.org/10.70517/revcc2624213
Published: 19/11/2026
: Muhammad Anees Farooqi, Afsheen Batool Raza, Ahmad Yar, Safwan Ahmad, Muhammad Usman Javed. Frequency of von Willebrand Disease Among Children With Bleeding Disorders at a Tertiary Care Hospital. Revista Cultura Científica, 2026 Issue 24. pg. 2660-2668.

Abstract

von Willebrand disease (VWD) is the most common inherited bleeding disorder and an important cause of mucocutaneous bleeding in children. Its reported frequency varies considerably among clinical populations with bleeding disorders, highlighting the importance of region-specific investigations. The objective of this study was to determine the frequency of VWD among children presenting with bleeding disorders at a tertiary care hospital. This descriptive cross-sectional study was conducted in the Department of Haematology and Oncology, The Children’s Hospital and University of Child Health Sciences, Lahore, from May to November 2025. A total of 143 consecutively recruited children aged 14 years or younger with clinically diagnosed bleeding disorders were evaluated. Venous blood samples were collected for von Willebrand factor ristocetin cofactor activity testing, and a value below 30 IU/dL was considered indicative of VWD under the study’s operational definition. Data were analysed using SPSS version 27.0, with descriptive statistics and chi-square tests for selected associations. According to the study criterion, VWD was identified in 19 of 143 children, giving a frequency of 13.3% (95% confidence interval: 8.2–19.9%). Among the 19 cases, 13 (68.4%) were reported as type 1, five (26.3%) as type 2, and one (5.3%) as type 3. A positive family history of bleeding and blood group O were associated with higher observed frequencies of VWD, with reported p-values of 0.01 and 0.03, respectively. The findings support considering VWD during the assessment of children with bleeding disorders, particularly when the family history is suggestive. However, a single ristocetin cofactor activity result does not provide complete diagnostic or subtype confirmation; comprehensive laboratory assessment remains necessary for accurate classification and clinical management.

Keywords: bleeding disorders, children, von Willebrand disease, von Willebrand factor, ristocetin cofactor activity, family history

Abstract

von Willebrand disease (VWD) is the most common inherited bleeding disorder and an important cause of mucocutaneous bleeding in children. Its reported frequency varies considerably among clinical populations with bleeding disorders, highlighting the importance of region-specific investigations. The objective of this study was to determine the frequency of VWD among children presenting with bleeding disorders at a tertiary care hospital. This descriptive cross-sectional study was conducted in the Department of Haematology and Oncology, The Children’s Hospital and University of Child Health Sciences, Lahore, from May to November 2025. A total of 143 consecutively recruited children aged 14 years or younger with clinically diagnosed bleeding disorders were evaluated. Venous blood samples were collected for von Willebrand factor ristocetin cofactor activity testing, and a value below 30 IU/dL was considered indicative of VWD under the study’s operational definition. Data were analysed using SPSS version 27.0, with descriptive statistics and chi-square tests for selected associations. According to the study criterion, VWD was identified in 19 of 143 children, giving a frequency of 13.3% (95% confidence interval: 8.2–19.9%). Among the 19 cases, 13 (68.4%) were reported as type 1, five (26.3%) as type 2, and one (5.3%) as type 3. A positive family history of bleeding and blood group O were associated with higher observed frequencies of VWD, with reported p-values of 0.01 and 0.03, respectively. The findings support considering VWD during the assessment of children with bleeding disorders, particularly when the family history is suggestive. However, a single ristocetin cofactor activity result does not provide complete diagnostic or subtype confirmation; comprehensive laboratory assessment remains necessary for accurate classification and clinical management.

Keywords: bleeding disorders, children, von Willebrand disease, von Willebrand factor, ristocetin cofactor activity, family history

References

  1. Abdulsalam, Abbas Hashim, et al. “Inherited Bleeding Disorders in Pediatric Patients; Experience of the National Referral Center in Iraq.” Indian Journal of Hematology and Blood Transfusion, vol. 37, no. 1, 2021, pp. 96–100. https://doi.org/10.1007/s12288-020-01306-8.

  2. James, Paula D., et al. “ASH ISTH NHF WFH 2021 Guidelines on the Diagnosis of von Willebrand Disease.” Blood Advances, vol. 5, no. 1, 2021, pp. 280–300. https://doi.org/10.1182/bloodadvances.2020003265.

  3. Weyand, Angela C., and Veronica H. Flood. “Von Willebrand Disease: Current Status of Diagnosis and Management.” Hematology/Oncology Clinics of North America, vol. 35, no. 6, 2021, pp. 1085–1101. https://doi.org/10.1016/j.hoc.2021.07.004.

  4. Connell, Nathan T., et al. “ASH ISTH NHF WFH 2021 Guidelines on the Management of von Willebrand Disease.” Blood Advances, vol. 5, no. 1, 2021, pp. 301–25. https://doi.org/10.1182/bloodadvances.2020003264.

  5. Franchini, Massimo, and Daniele Focosi. “Targeting von Willebrand Disease: The Current Status and Future Directions of Management Therapies.” Expert Review of Hematology, vol. 16, no. 11, 2023, pp. 871–78. https://doi.org/10.1080/17474086.2023.2268282.

  6. Du, Ping, et al. “Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review.” Journal of Blood Medicine, vol. 14, 2023, pp. 189–208. https://doi.org/10.2147/JBM.S389241.

  7. Swallow, Elyse, et al. “Burden of Illness and Treatment Patterns among Patients with von Willebrand Disease in US Clinical Practice.” Clinical and Applied Thrombosis/Hemostasis, vol. 29, 2023, article 10760296231177023. https://doi.org/10.1177/10760296231177023.

  8. Abe, Karon, et al. “Higher Rates of Bleeding and Use of Treatment Products among Young Boys Compared to Girls with von Willebrand Disease.” American Journal of Hematology, vol. 95, no. 1, 2020, pp. 10–17. https://doi.org/10.1002/ajh.25656.

  9. Roberts, Jonathan C., et al. “Bleeding Patterns in Patients before and after Diagnosis of von Willebrand Disease: Analysis of a US Medical Claims Database.” Haemophilia, vol. 28, no. 1, 2022, pp. 97–108. https://doi.org/10.1111/hae.14448.

  10. Ahmad, Nehal, et al. “Spectrum of Inherited Bleeding Disorder with Special Reference to von Willebrand Disease in Eastern India.” Journal of Laboratory Physicians, vol. 14, no. 4, 2022, pp. 465–70. https://doi.org/10.1055/s-0042-1748827.

  11. Owaidah, Tarek, et al. “Clinical and Laboratory Presentation of von Willebrand Disease: Experience from a Single Center in Saudi Arabia.” Journal of Taibah University Medical Sciences, vol. 18, no. 2, 2023, pp. 413–19. https://doi.org/10.1016/j.jtumed.2022.10.019.

  12. Connell, Nathan T., et al. “Von Willebrand Disease: Proposing Definitions for Future Research.” Blood Advances, vol. 5, no. 2, 2021, pp. 565–69. https://doi.org/10.1182/bloodadvances.2020003620.

  13. Agrawal, Nikita, Sangeeta Pahuja, and Sunita Sharma. “Von Willebrand Factor Levels in Healthy Blood Donors and Their Association with Blood Group: A Tertiary Care Hospital-Based Study.” Asian Journal of Transfusion Science, vol. 17, no. 1, 2023, pp. 28–33. https://doi.org/10.4103/ajts.AJTS_107_20.

  14. Favaloro, Emmanuel J., and Leonardo Pasalic. “Laboratory Diagnosis of von Willebrand Disease in the Age of the New Guidelines: Considerations Based on Geography and Resources.” Research and Practice in Thrombosis and Haemostasis, vol. 7, no. 5, 2023, article 102143. https://doi.org/10.1016/j.rpth.2023.102143.

  15. Christopherson, Pamela A., et al. “Ristocetin Dependent Cofactor Activity in von Willebrand Disease Diagnosis: Limitations of Relying on a Single Measure.” Research and Practice in Thrombosis and Haemostasis, vol. 6, no. 7, 2022, article e12807. https://doi.org/10.1002/rth2.12807.

  16. Kalot, Mohamad A., et al. “Von Willebrand Factor Levels in the Diagnosis of von Willebrand Disease: A Systematic Review and Meta-analysis.” Blood Advances, vol. 6, no. 1, 2022, pp. 62–71. https://doi.org/10.1182/bloodadvances.2021005430.

  17. Kaur, Varinder, et al. “Von Willebrand Disease: A Guide for the Internist.” Cleveland Clinic Journal of Medicine, vol. 91, no. 2, 2024, pp. 119–27. https://doi.org/10.3949/ccjm.91a.22033.

  18. Abou-Ismail, Mouhamed Yazan, et al. “Beyond the Guidelines: How We Approach Challenging Scenarios in the Diagnosis and Management of von Willebrand Disease.” Journal of Thrombosis and Haemostasis, vol. 21, no. 2, 2023, pp. 204–14. https://doi.org/10.1016/j.jtha.2022.11.042.

  19. Tang, Grace H., et al. “Patient-Centered Care in von Willebrand Disease: Are We There Yet?” Expert Review of Hematology, vol. 16, no. 9, 2023, pp. 641–49. https://doi.org/10.1080/17474086.2023.2243386.

Muhammad Anees Farooqi
Department of Paediatric Medicine, The Children's Hospital and University of Child Health Sciences, Lahore, Pakistan
Afsheen Batool Raza
Department of Paediatric Medicine, The Children's Hospital and University of Child Health Sciences, Lahore, Pakistan
Ahmad Yar
Department of Paediatric Medicine, The Children's Hospital and University of Child Health Sciences, Lahore, Pakistan
Safwan Ahmad
Department of Paediatric Haematology and Oncology, The Children's Hospital and Institute of Child Health, Multan, Pakistan
Muhammad Usman Javed
Department of Pathology, Sahara Medical College, Narowal, Pakistan

How to cite:

Muhammad Anees Farooqi, Afsheen Batool Raza, Ahmad Yar, Safwan Ahmad, Muhammad Usman Javed. Frequency of von Willebrand Disease Among Children With Bleeding Disorders at a Tertiary Care Hospital. Revista Cultura Científica, 2026 Issue 24. pg. 2660-2668.

Publication History

Copyright © 2026, Muhammad Anees Farooqi, Afsheen Batool Raza, Ahmad Yar, Safwan Ahmad, Muhammad Usman Javed. Published by Revista Cultura Científica. This article is published as open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) license (http://creativecommons.org/licenses/by/4.0/).

Browse Advance Search